Clinical Trial

Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-01-02; most recent amendment 2026-06-17.
Status change: Not Yet Recruiting → Recruiting 2024-08-01
Trial Details
NCT Number NCT06203938
Lead Sponsor Francisco Gonzalez-Lima, PhD
Conditions Autism Spectrum Disorder
Enrollment 280 participants
Start Date 2025-01-13
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-22